BTIG Research initiated coverage on shares of Orchestra BioMed (NASDAQ:OBIO – Free Report) in a report released on Thursday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $12.
4/18-19: The Downtown Defrost: Channel Tres, Yaeji, Neil Frances, Justin Martin (Churchill Square) 5/12: Shred Fest 2025: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback